Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Emerging Drugs|April 15, 2021
Emerging synthetic drugs for the treatment of liver cirrhosisJonathan Andrew Fallowfield, Maria Jimenez-Ramos, Andrew RobertsonIscience|January 3, 2022
In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applicationsMaria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, et al.Annals of Hepatology|December 22, 2023
A data-driven approach to decode metabolic dysfunction-associated steatotic liver diseaseMaria Jimenez Ramos, Timothy J Kendall, Ignat Drozdov, et al.Stem Cell Research & Therapy|March 12, 2025
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissueAlvile Kasarinaite, Maria Jimenez Ramos, Mariana Beltran-Sierra, et al.Nature Medicine|October 31, 2023
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J Kendall, Maria Jimenez-Ramos, Frances Turner, et al.Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.Cell Reports. Medicine|December 10, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.Pageof 1